// App-Quantinova.ai

2634 : A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Wing H. Tong

Principal Investigators

  • Rob Pieters

  • Gertjan Kaspers

  • Wim J Tissing

  • Inge M. van der Sluis

  • Maroeska D.W.M. te Loo

  • Marc B. Bierings

  • Cor van den Bos

  • Wouter J.W. Kollen

  • Wim C.J. Hop

  • Joachim Boos

  • Mary V. Relling

  • Hans Juergen Kuehnel

Medical Centers

  • medac GmbH, Wedel, Germany

  • Paediatrics, Emma Childrens Hospital - AMC, Amsterdam, Netherlands

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN

  • Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany

  • Department of Biostatistics, Erasmus University Medical Center, Rotterdam, Netherlands

  • Department of Medical Statistics, Leiden University Medical Center, Leiden, Netherlands

  • Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands

  • Pediatric Hemato-Oncology, UMCN St Radboud, Nijmegen, Netherlands

  • Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Locations

  • United States

  • Germany

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Erwinase

  • Hydrocortisone

  • Asparaginase

  • Clemastine

  • Glutamine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved